Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · IEX Real-Time Price · USD
3.530
+0.220 (6.65%)
At close: Jun 21, 2024, 4:00 PM
3.528
-0.002 (-0.06%)
After-hours: Jun 21, 2024, 4:16 PM EDT

Lisata Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 1995
Cash & Equivalents
22.5932.1524.6516.5114.03
Upgrade
Short-Term Investments
27.9437.0770.3218.0611.13
Upgrade
Cash & Cash Equivalents
50.5469.2394.9734.5725.16
Upgrade
Cash Growth
-27.00%-27.11%174.69%37.43%-41.57%
Upgrade
Other Current Assets
3.392.651.210.760.82
Upgrade
Total Current Assets
53.9271.8896.1835.3325.97
Upgrade
Property, Plant & Equipment
0.180.30.060.060.1
Upgrade
Goodwill and Intangibles
0.260.33000
Upgrade
Other Long-Term Assets
0.330.530.760.611.08
Upgrade
Total Long-Term Assets
0.771.160.830.671.18
Upgrade
Total Assets
54.6973.0397.013627.15
Upgrade
Accounts Payable
2.422.661.931.021.49
Upgrade
Other Current Liabilities
4.173.732.592.494.49
Upgrade
Total Current Liabilities
6.596.384.523.515.98
Upgrade
Other Long-Term Liabilities
0.210.330.490.250.62
Upgrade
Total Long-Term Liabilities
0.210.330.490.250.62
Upgrade
Total Liabilities
6.86.715.013.766.6
Upgrade
Retained Earnings
-528.08-507.24-453.02-425.55-417.4
Upgrade
Comprehensive Income
-0.04-0.03-0.07-0.010
Upgrade
Shareholders' Equity
48.1566.5892.2532.520.82
Upgrade
Net Cash / Debt
50.5469.2394.9734.5725.16
Upgrade
Net Cash / Debt Growth
-27.00%-27.11%174.69%37.43%-41.57%
Upgrade
Net Cash Per Share
6.2613.3625.7533.5936.55
Upgrade
Working Capital
47.3365.4991.6631.8320
Upgrade
Book Value Per Share
5.9612.8525.0231.5730.24
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).